CIK: 0001536114 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 5, 2019
Total Value ($000): $144,278 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VGSH | VANGUARD SCOTTSDALE FDS | 1,087,088 | $66,258 | 45.9% | $60.33 | — | SHTRM GVT BD ETF | 92206C102 |
| VOO | VANGUARD INDEX FDS | 131,165 | $35,756 | 24.8% | $221.94 | — | S&P 500 ETF SHS | 922908363 |
| VEU | MFC VANGUARD INTL EQUITY INDEX FDS | 588,511 | $29,367 | 20.4% | $45.31 | — | ALLWRLD EX US | 922042775 |
| — | REATA PHARMACEUTICALS INC | 160,628 | $12,897 | 8.9% | $80.29 | — | CLASS A | 75615P103 |